Gold Rate

Nectar Lifesciences Ltd.

BSE: 532649 | NSE: NECLIFE |

Shares falling in the `Trade-to-Trade` or `T-segment` are traded in this series and no intraday is allowed. This means trades can only be settled by accepting or giving the delivery of shares.

Series: BE | ISIN: INE023H01027 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Nectar Lifesci Nectar Lifesciences Ltd. | BSE 20.15 -0.32 (-1.56%) | NSE 20.12 -0.26 (-1.28%) | Trade | Add

BSE Live

Jan 02, 16:01

20.15 -0.32 (-1.56%)

Volume

AVERAGE VOLUME

5-Day

74,716

10-Day

173,736

30-Day

466,808

94,794

Prev. Close

20.47
Open Price

20.94

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 02, 15:55

20.12 -0.26 (-1.28%)

Volume

AVERAGE VOLUME

5-Day

414,155

10-Day

1,602,544

30-Day

4,599,470

592,356

Prev. Close

20.38
Open Price

20.80

Bid Price (Qty.)
20.12 (2341)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Cash Flow of Nectar Lifesciences (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
Net Profit/Loss Before Extraordinary Items And Tax	-161.53	18.27	-42.42	34.08	-59.45
Net CashFlow From Operating Activities	169.44	224.69	133.65	95.01	21.38
Net Cash Used In Investing Activities	-41.93	-17.03	51.70	16.64	-28.62
Net Cash Used From Financing Activities	-128.09	-205.44	-185.58	-119.38	11.49
Foreign Exchange Gains / Losses	0.00	0.00	0.00	0.00	0.00
Adjustments On Amalgamation Merger Demerger Others	0.00	0.00	0.00	0.00	0.00
Net Inc/Dec In Cash And Cash Equivalents	-0.58	2.23	-0.23	-7.73	4.25
Cash And Cash Equivalents Begin of Year	19.81	17.58	17.81	25.54	21.29
Cash And Cash Equivalents End Of Year	19.22	19.81	17.58	17.81	25.54